Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-SMC element 4 homolog A pseudogene is a processed or duplicated pseudogene related in sequence to the parent NSMCE4A gene, which is involved in chromosome maintenance and structural functions in cells. Pseudogenes such as this one are nonfunctional DNA elements that arise either by duplication of a functional gene followed by disabling mutations (duplicated pseudogene) or by retrotransposition of an mRNA transcript back into the genome (processed pseudogene). They do not encode functional proteins, do not serve as therapeutic targets, and do not participate directly in disease processes. Occasionally, some pseudogenes may be transcribed and have minor regulatory roles, but such functions are rare and not attributed to this pseudogene in any major reference database. This target is not a protein, receptor, enzyme, transporter, or other druggable entity. It should not be considered as a candidate for pharmacological intervention, biomarker research, or clinical translation.
None; no mechanism of action because it is not a drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-SMC element 4 homolog A pseudogene.